ZK International Group Co., Ltd. (Nasdaq: ZKIN) ("ZK International" or the "Company"), a leading engineering Company focused ...
BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop ...
ZK International Group (ZKIN) announces 1-for-7 reverse stock split to meet NASDAQ listing requirements, effective Jan.
under the exiting symbol "ZKIN". The new CUSIP number for the ordinary shares following the reverse stock split will be G9892K209. Upon effectiveness of the reverse stock split, every 7 shares of ...
under the exiting symbol "ZKIN". The new CUSIP number for the ordinary shares following the reverse stock split will be G9892K209. Upon effectiveness of the reverse stock split, every 7 shares of the ...
Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.
The Board of Directors approved the reverse stock split proposal at the Company's Board Meeting held on August 7, 2024 ... to trade on Nasdaq under the symbol "FCUV" but will trade under a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback